Print | Email Page

Jefferies and Barclays complete $231 million public offering of Common Stock by AMAG Pharmaceuticals

August 2015

Jones Day advised Jefferies LLC and Barclays Capital Inc., as representatives of the underwriters, in connection with the $231 million public offering of Common Stock by AMAG Pharmaceuticals, Inc., a specialty pharmaceutical company with a focus on maternal health, anemia, and cancer supportive care.

For additional information about this matter, please contact: Rory T. Hood

Client(s): Jefferies LLC and Barclays Capital Inc.